Table 2 Characteristics of study participants

n

13,141

3905

4721

1760

2755

Age

53.0 (7.1)

54.5 (5.7)

53.8 (5.6)

51.0 (9.0)

50.8 (8.9)

BMI

27.8 (5.7)

27.2 (3.8)

26.1 (5.0)

28.3 (5.4)

31.4 (7.2)

Waist circumference

95.9 (13.7)

98.9 (10.0)

91.5 (13.6)

97.4 (13.8)

98.1 (16.3)

SBP

120.0 (17.5)

119.2 (15.3)

116.0 (17.2)

126.4 (18.4)

123.6 (18.3)

HDL

52.6 (16.6)

43.6 (12.2)

58.9 (16.8)

48.6 (15.1)

57.1 (16.1)

Triglycerides

118. 5 (73.8)

138.6 (84.6)

119.1 (68.3)

109.5 (77.8)

95.0 (53.1)

Glucose

96.9 (9.7)

100.8 (8.8)

96.6 (8.6)

95.2 (10.3)

93.2 (10.5)

MetS severity score

0.0 (0.8)

0.3 (0.7)

− 0.1 (0.8)

− 0.1 (0.7)

− 0.0 (0.8)

Framingham predicted 10-year CVD risk

0.101 (0.086)

0.150 (0.091)

0.061 (0.049)

0.152 (0.106)

0.069 (0.058)

ASCVD predicted 10-year risk

0.057 (0.053)

0.081 (0.052)

0.029 (0.027)

0.095 (0.062)

0.048 (0.057)

Incident CVD at 10 years; n (%)

1740 (13.2%)

959 (24.6%)

444 (9.4%)

181 (10.3%)

156 (5.7%)

Incident T2DM at 10 years, n (%)

1573 (12.0%)

456 (11.7%)

375 (7.9%)

288 (16.4%)

454 (16.5%)